Allergan, Molecular Partners target retinal disease with agreement
May 11th 2011Allergan Inc. and Molecular Partners AG have entered into a license agreement for a phase II proprietary therapeutic protein being investigated as a possible treatment for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME)..
ASCRS Foundation eligible in CFC list
May 11th 2011Beginning in 2012, federal employees will be able to donate to the American Society of Cataract and Refractive Surgery (ASCRS) Foundation through payroll deductions. ?The ASCRS Foundation is pleased to be eligible for inclusion in the Combined Federal Campaign (CFC) charity list,? said ASCRS Chairman Richard Lindstrom, MD.
Parry becomes new AMDAI chairman
May 11th 2011Hugh R. Parry has been named chairman of the board of AMD Alliance International (AMDAI), an international organization dedicated exclusively to macular disease.Parry, president and CEO of Prevent Blindness America, was appointed during the annual board meeting of AMDAI in New York on April 16, 2010.
BPEI to aid quake victims in Japan
April 20th 2011The Bascom Palmer Eye Institute (BPEI) of the University of Miami Miller School of Medicine and Keio University School of Medicine in Tokyo have launched a Japan Eye Rescue Mission to assist that country with recovery from the Tohoku-Pacific Ocean Earthquake.
Longer allergy season tough on eyes
April 20th 2011The length of the ragweed season at latitudes above 44 degrees North ?which includes many states in the midwestern and northeastern U.S. ? has increased by as much as 13 to 27 days since 1995, according to a study published in the Proceedings of the National Academy of Sciences.